Anna Macia
Lleida, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
ARID1A deficiency reprograms the tumor secretome, enhancing microenvironmental remodeling and metastatic dissemination in endometrial carcinoma.
Journal: Cell death & disease
Published: July 07, 2025
High Copy Number Variations Correlate with a Pro-Tumoral Microenvironment and Worse Prognosis in Acral Lentiginous Melanoma.
Journal: International journal of molecular sciences
Published: March 19, 2025
Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review.
Journal: Cancers
Published: November 22, 2023
Molecular Profile of Subungual Melanoma: A MelaNostrum Consortium Study of 68 Cases Reporting BRAF, NRAS, KIT, and TERT Promoter Status.
Journal: Dermatology (Basel, Switzerland)
Published: July 22, 2023
Live Cell Adhesion, Migration, and Invasion Assays.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: May 04, 2023
A dominant negative mutation uncovers cooperative control of caudal Wolffian duct development by Sprouty genes.
Journal: Cellular and molecular life sciences : CMLS
Published: April 27, 2022
M-CSF as a therapeutic target in BRAFV600E melanoma resistant to BRAF inhibitors.
Journal: British journal of cancer
Published: November 23, 2021
Differential Immunoexpression of BRAF/V600E, Senescence Markers, PTEN, and T-type Calcium Channels in Acquired Naevi According to their Histopathological and Dermoscopic Classification.
Journal: Acta dermato-venereologica
Published: October 13, 2021
ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma.
Journal: Molecular oncology
Published: September 23, 2021
Last Updated: 09/26/2026